Temozolomide Capsule
Product Images NDC 70301-2005

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Temozolomide (NDC 70301-2005). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Opko Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Figure)

Figure (Figure)
Kaplan-Meier curves for overall survival in patients with newly diagnosed glioblastoma, comparing those treated with radiation therapy plus temozolomide (RT + TMZ) versus radiation therapy alone (RT Only). The graph plots overall survival percentage over time in months, showing higher survival rates for the RT + TMZ group throughout the observed period up to 40 months.*
FDA Label Image

Label09 (Label09)

Label09 (Label09)
Carton label for Temozolomide Capsules, USP, 100 mg strength. The label features the product name prominently in bold text, with '100 mg per capsule' highlighted in a colored box on the front and side panels. The NDC is 70301-2005-1 and the labeler is OPKO Pharmaceuticals, LLC. The label also includes dosage and content information advising to see prescribing information for recommended dosage.*
FDA Label Image

Label10 (Label10)

Label10 (Label10)
Temozolomide Capsule USP 100 mg oral capsules label from OPKO Pharmaceuticals, LLC. The label includes the product name, strength in milligrams, distributor information, a barcode, and a warning about hazardous drug handling with instructions to read directions carefully. The label dimensions and layout markings are also shown around the edges.*
FDA Label Image

Label11 (Label11)

Label11 (Label11)
Temozolomide Capsules, USP 100 mg oral capsules packaging label from OPKO Pharmaceuticals, LLC. The label displays the product name, strength, dosage form, and warnings that it is a hazardous drug for oral administration. It includes storage instructions, dosage recommendations, a barcode, and states the package contains 14 individual sachets each with one capsule.*
FDA Label Image

Label12 (Label12)

Label12 (Label12)
Label for Temozolomide Capsule, USP, 100 mg oral capsules by OPKO Pharmaceuticals, LLC. The front panel shows the drug name, strength 100 mg, distributor details in Miami, FL, along with a warning that it is a hazardous drug and instructions to read accompanying directions carefully. The back panel includes bar code, lot, and expiration placeholders.*
FDA Label Image

Chemical Structure (Temo Structure)

Chemical Structure (Temo Structure)
Chemical structure of the active ingredient temozolomide showing a fused bicyclic ring system with attached functional groups including a methyl group and an amide moiety.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.